Reply

Elad Moisseiev^{1

2}, Anat Loewenstein^{2

3}

Affiliations

Comment

Elad Moisseiev et al. Retina. 2025.

. 2025 Jan 1;45(1):e4.

doi: 10.1097/IAE.0000000000004292.

Elad Moisseiev^{1

2}, Anat Loewenstein^{2

3}

No abstract available

Comment on

ACCURACY AND PRECISION OF INTRAVITREAL INJECTIONS OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN REAL LIFE: What Is Actually in the Syringe?
Loewenstein I, Goldstein M, Moisseiev J, Moisseiev E. Loewenstein I, et al. Retina. 2019 Jul;39(7):1385-1391. doi: 10.1097/IAE.0000000000002170. Retina. 2019. PMID: 29659411
Intravitreal air bubbles following intravitreal injections: a comprehensive analysis.
Krauthammer M, Trabelsi E, Moisseiev E. Krauthammer M, et al. Graefes Arch Clin Exp Ophthalmol. 2021 Dec;259(12):3697-3702. doi: 10.1007/s00417-021-05302-0. Epub 2021 Jul 14. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 34258656
The Effect of Syringe-Filling Technique on the Risk for Endophthalmitis after Intravitreal Injection of Anti-VEGF Agents.
Finkelstein M, Katz G, Zur D, Rubowitz A, Moisseiev E. Finkelstein M, et al. Ophthalmologica. 2022;245(1):34-40. doi: 10.1159/000518236. Epub 2021 Jul 23. Ophthalmologica. 2022. PMID: 34348344
SYRINGE DESIGN AND FILLING TECHNIQUE AFFECT ACCURACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INTRAVITREAL INJECTIONS.
Krauthammer M, Harel G, Moisseiev E. Krauthammer M, et al. Retina. 2023 Mar 1;43(3):514-519. doi: 10.1097/IAE.0000000000003693. Retina. 2023. PMID: 36729828

1. Loewenstein I, Goldstein M, Moisseiev J, Moisseiev E. Accuracy and precision of intravitreal injections of anti-vascular endothelial growth factor agents in real life: what is actually in the syringe? Retina 2019;39:1385–1391.
1. Krauthammer M, Harel G, Moisseiev E. Syringe design and filling technique affect accuracy of anti-vascular endothelial growth factor intravitreal injections. Retina 2023;43:514–519.
1. Krauthammer M, Trabelsi E, Moisseiev E. Intravitreal air bubbles following intravitreal injections: a comprehensive analysis. Graefes Arch Clin Exp Ophthalmol 2021;259:3697–3702.
1. Finkelstein M, Katz G, Zur D, et al. The effect of syringe-filling technique on the risk for endophthalmitis after intravitreal injection of anti-VEGF agents. Ophthalmologica 2022;245:34–40.
1. Storey PP, Tauqeer Z, Yonekawa Y, et al. The impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab. Am J Ophthalmol 2019;199:200–208.